2022
October 3rd
October 7th
Poster Breast Cancer 2022
International course

Breast Cancer

5th Course - From Clinics to Biology

This 5th edition of the international breast cancer course organized by the Institut Curie offers a comprehensive overview of current topics on clinical and biological aspects of breast cancer. This course brings together internationally renowned experts who will present the latest innovations in the clinical management of breast cancer, on both diagnostic and therapeutic aspects, as well as the latest advances in the understanding of biological mechanisms such as plasticity, tumor heterogeneity or genomics of breast cancer. The focus will be on the latest cutting-edge technologies and innovative approaches, including artificial intelligence and single cell analysis. There will also be a focus on luminal B breast cancers, including lobular carcinomas.

The format of the course is designed to encourage exchanges and to allow students to interact with researchers from the Institut Curie and from several international institutes.

You may register for a virtual attendance.

>> REGISTER HERE <<

Note: If you have already registered in the course using the previous form, you do not need to do it again.

Course in English
Registration deadline

Presentation

Objectives

The objectives of the 5th edition of the international breast cancer course are:

- to provide students with an overview of the latest clinical and biological advances in breast cancer

- to encourage exchanges through student presentations and poster sessions

- to allow students to reflect on their careers through the « Research in Pharma » and “Publishing your paper” sessions

Personal Work

- project presentation (3 minutes)

- poster or flash talk (optional)

ECTS Information

N/A

Exam & Evaluation

There will be a prize delivered for the following two evaluations:

- Participation during the course (questions asked to the speakers)

- Poster or flash talk

Practical Informations

Practical Informations

You may register for a virtual attendance.

For the on-site attendance, students will be responsible for all costs associated with accommodation and transportation. Food will be provided during the course (lunches + cocktail evening).

Selection result
September 15, 2022
There is no registration fee for this course
Place
Institut Curie - Bâtiment de Biologie du Développement - Amphithéâtre
11 Rue Pierre et Marie Curie
75248 Paris cedex 05
France

Maximum Number of Participants

35 people

Number of Participants

35 participants

Selection Criteria

Selection based on resume and letter of motivation

Speakers

Speakers

François-Clément BIDARD - FR

Irène BUVAT - FR

Collectif TRIPLETTES ROSES - FR

Suzette DELALOGE - FR

Silvia FRE - FR

Mathilde HIS - FR

Priscilla KELLY - US

Youlia KIROVA - FR

Caroline MALHAIRE - FR

Eliane PIAGGIO - FR

Yolanda PREZADO - FR

Andy RANKIN - US

Fabien REYAL - FR

Raphaël RODRIGUEZ - FR

Emanuela ROMANO - FR

Meriem SEFTA - FR

Marc-Henri STERN - FR

Dominique STOPPA-LYONNET - FR

Céline VALLOT - FR

Anne VINCENT-SALOMON - FR

Keynote speakers

Fabrice ANDRÉ - FR

Carlos CALDAS - UK

Patrick DERKSEN - NL

Christine DESMEDT - BE

Jos JONKERS - NL

Guido KROEMER - FR

Diether LAMBRECHTS - BE

Jeffrey POLLARD - UK

Kornelia POLYAK - US

Alain PUISIEUX - FR

Jorge REIS-FILHO - US

Georgios SFLOMOS - CH

Christos SOTIRIOU - BE

Andrew TUTT - UK

Jean-Philippe VERT - FR

Laurence ZITVOGEL - FR

This list of speakers may still change

Organizers

Anne Vincent-Salomon, Institut Curie, Diagnostic and Theranostic Medicine Division

Fatima Mechta-Grigoriou, Institut Curie, Stress & Cancer Lab

François-Clément Bidard, Institut Curie, PU-PH UVSQ, Circulating Cancer Biomarkers Lab

Anastasia Lanzi, Institut Curie, Breast Cancer Medico-Scientific Program

Scientific Committee

Anne Vincent-Salomon, Institut Curie, Diagnostic and Theranostic Medicine Division

Fatima Mechta-Grigoriou, Institut Curie, Stress & Cancer Lab

François-Clément Bidard, Institut Curie, PU-PH UVSQ, Circulating Cancer Biomarkers Lab

Anastasia Lanzi, Institut Curie, Breast Cancer Medico-Scientific Program